VertiFlex® Inc. a leading innovator of advanced minimally invasive interventions for spinal stenosis announced today that the U.S. Food and Drug Administration (FDA) has issued a PMA Approval Order for the company’s Superion® Interspinous Spacer System clearing the way for commercialization